References

• 1999Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic191 cited
• 1999Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects140 cited
• 2000A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia122 cited
• 1998Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*115 cited
• 1999A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening113 cited
• 2000Comparison of the Effects of Zaleplon, Zolpidem, and Triazolam on Memory, Learning, and Psychomotor Performance99 cited
• 1998Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance94 cited
• 2000Zaleplon improves sleep without producing rebound effects in outpatients with insomnia93 cited
• 2000Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia93 cited
• 2000Lack of Residual Sedation Following Middle-of-the-Night Zaleplon Administration in Sleep Maintenance Insomnia88 cited
• 1994A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine Hypnotic82 cited

Cited by

No citing works inside the corpus for this window.